{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:16:38Z","timestamp":1790504198538,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Parasit Dis"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12639-019-01111-9","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T10:02:31Z","timestamp":1553940151000},"page":"464-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Toxoplasma gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level"],"prefix":"10.1007","volume":"43","author":[{"given":"Mona Ibrahim","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6269-603X","authenticated-orcid":false,"given":"Wegdan Mohamed","family":"Abd El Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6235-7174","authenticated-orcid":false,"given":"Doaa Ahmed","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,30]]},"reference":[{"key":"1111_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3923\/aje.2018.52.58","volume":"11","author":"WM Abd El Wahab","year":"2018","unstructured":"Abd El Wahab WM, Shaapan RM, Hassanain MA, Elfadaly HA, Hamdy DA (2018) Toxoplasma gondii infection and associated sociodemographic and behavioral risk factors among blood donors. Asian J Epidemiol 11:52\u201358. https:\/\/doi.org\/10.3923\/aje.2018.52.58","journal-title":"Asian J Epidemiol"},{"key":"1111_CR2","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.22034\/APJCP.2018.19.7.1987","volume":"19","author":"RR Abdel Malek","year":"2018","unstructured":"Abdel Malek RR, Wassef RM, Rizk EM, Sabry H, Tadros N, Boghdady AM (2018) Toxoplasmosis an overlooked disease: seroprevalence in cancer patients. Asian Pac J Cancer Prev 19:1987\u20131991. https:\/\/doi.org\/10.22034\/APJCP.2018.19.7.1987","journal-title":"Asian Pac J Cancer Prev"},{"key":"1111_CR3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.32007\/jfacmedbagdad.541776","volume":"54","author":"HI Abdul-Lateef","year":"2012","unstructured":"Abdul-Lateef HI, AL-Najar YSA, Abul Majeed NG (2012) The levels of IFN-, IL-12 and testosterone hormone in persons with toxoplasmosis. Fac Med Baghdad 54:79\u201382","journal-title":"Fac Med Baghdad"},{"key":"1111_CR4","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1128\/IAI.72.3.1397-1401.2004","volume":"17","author":"A Abou-Bacar","year":"2004","unstructured":"Abou-Bacar A, Pfaff AW, Georges S, Letscher-BruV Filisetti D, Villard O et al (2004) Role of NK cells and gamma interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection. Infect Immune 17:1397\u20131401. https:\/\/doi.org\/10.1128\/IAI.72.3.1397-1401.2004","journal-title":"Infect Immune"},{"key":"1111_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.7197\/223.vi.387046","volume":"40","author":"M Alim","year":"2018","unstructured":"Alim M, \u00d6z\u00e7elik S, \u00d6zp\u0131nar N (2018) Seroprevalence of Toxoplasma gondii in patients receiving cancer treatment. Cumhur Med J 40:731\u2013736. https:\/\/doi.org\/10.7197\/223.vi.387046","journal-title":"Cumhur Med J"},{"key":"1111_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4049\/jimmunol.1201209","volume":"190","author":"JR Baird","year":"2013","unstructured":"Baird JR, Byrne KT, Lizotte PH, Toraya-Brown S, Scarlett UK, Alexander MP et al (2013) Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge. J Immunol 190:469\u2013478","journal-title":"J Immunol"},{"key":"1111_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.mib.2011.07.003","volume":"14","author":"M Baumgartner","year":"2011","unstructured":"Baumgartner M (2011) Enforcing host cell polarity: an apicomplexan parasite strategy towards dissemination. Curr Opin Microbiol 14:436\u2013444. https:\/\/doi.org\/10.1016\/j.mib.2011.07.003","journal-title":"Curr Opin Microbiol"},{"key":"1111_CR8","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1128\/IAI.69.8.4898-4905.2001","volume":"69","author":"SK Bliss","year":"2001","unstructured":"Bliss SK, Gavrilescu LC, Alcaraz A, Denkersi EY (2001) Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology. Infect Immune 69:4898\u20134905. https:\/\/doi.org\/10.1128\/IAI.69.8.4898-4905.2001","journal-title":"Infect Immune"},{"key":"1111_CR9","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1365-2958.2007.05714.x","volume":"64","author":"JC Carmen","year":"2007","unstructured":"Carmen JC, Sinai AP (2007) Suicide prevention: disruption of apoptotic pathways by protozoan parasites. Mol Microbiol 64:904\u2013916. https:\/\/doi.org\/10.1111\/j.1365-2958.2007.05714.x","journal-title":"Mol Microbiol"},{"key":"1111_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1128\/CMR.11.4.569","volume":"11","author":"EY Denkers","year":"1998","unstructured":"Denkers EY, Gazzinelli RT (1998) Regulation and function of T-cell-mediated immunity during T. gondii infection. Clin Microbiol Rev 11:569\u2013588","journal-title":"Clin Microbiol Rev"},{"key":"1111_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"GP Dunn","year":"2002","unstructured":"Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3:991\u2013998. https:\/\/doi.org\/10.1038\/ni1102-991","journal-title":"Nat Immunol"},{"key":"1111_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.actatropica.2012.08.005","volume":"124","author":"HK Deeb El","year":"2012","unstructured":"El Deeb HK, Salah Eldin H, Khodeer S, Allah AA (2012) Prevalence of Toxoplasma gondii infection in antenatal population in Menoufia, governorate Egypt. Acta Trop 124:185\u2013191. https:\/\/doi.org\/10.1016\/j.actatropica.2012.08.005","journal-title":"Acta Trop"},{"key":"1111_CR13","first-page":"781","volume":"26","author":"AM Shazly El","year":"1996","unstructured":"El Shazly AM, Afify EM, Morsy TA (1996) Antibodies against toxoplasma in children and adults with malignancy. J Egypt Soc Parasitol 26:781\u2013787","journal-title":"J Egypt Soc Parasitol"},{"key":"1111_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/1687-7942.192992","volume":"9","author":"OA El-Geddawi","year":"2016","unstructured":"El-Geddawi OA, El-Sayad MH, Sadek NA, Hussien NA, Ahmed MA (2016) Detection of T. gondii infection in blood donors in Alexandria, Egypt, using serological and molecular strategies. J Egypt Soc Parasitol 9:24\u201330. https:\/\/doi.org\/10.4103\/1687-7942.192992","journal-title":"J Egypt Soc Parasitol"},{"key":"1111_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-3024.2006.00886.x","volume":"28","author":"T Evering","year":"2006","unstructured":"Evering T, Weiss LM (2006) The immunology of parasite infections in immunocompromized hosts. Parasite Immunol 28:549\u2013565. https:\/\/doi.org\/10.1111\/j.1365-3024.2006.00886.x","journal-title":"Parasite Immunol"},{"key":"1111_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0065-308X(08)00602-7","volume":"68","author":"PW Ewald","year":"2009","unstructured":"Ewald PW (2009) An evolutionary perspective on parasitism as a cause of cancer. Adv Parasitol 68:21\u201343. https:\/\/doi.org\/10.1016\/S0065-308X(08)00602-7","journal-title":"Adv Parasitol"},{"key":"1111_CR17","first-page":"71","volume":"40","author":"D Filisetti","year":"2004","unstructured":"Filisetti D, Candolfi E (2004) Immune response to Toxoplasma gondii. Annali dell\u2019Istituto Superiore di Sanit\u00e0 40:71\u201380","journal-title":"Annali dell\u2019Istituto Superiore di Sanit\u00e0"},{"key":"1111_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.pt.2013.07.001","volume":"29","author":"BA Fox","year":"2013","unstructured":"Fox BA, Sanders KL, Chen S, Bzik DJ (2013) Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines. Trends Parasitol 29:431\u2013437. https:\/\/doi.org\/10.1016\/j.pt.2013.07.001","journal-title":"Trends Parasitol"},{"key":"1111_CR19","doi-asserted-by":"publisher","first-page":"e1006189","DOI":"10.1371\/journal.pgen.1006189","volume":"12","author":"BA Fox","year":"2016","unstructured":"Fox BA, Sanders KL, Rommereim LM, Guevara RB, Bzik DJ (2016) Secretion of rhoptry and dense granule effector proteins by non replicating Toxoplasma gondii uracil auxotrophs controls the development of antitumor immunity. PLoS Genet 12:e1006189. https:\/\/doi.org\/10.1371\/journal.pgen.1006189","journal-title":"PLoS Genet"},{"key":"1111_CR20","doi-asserted-by":"publisher","first-page":"e1006523","DOI":"10.1371\/journal.ppat.1006523","volume":"13","author":"BA Fox","year":"2017","unstructured":"Fox BA, Butler KL, Guevara RB, Bzik DJ (2017) Cancer therapy in a microbial bottle: uncorking the novel biology of the protozoan Toxoplasma gondii. PLoS Pathog 13:e1006523. https:\/\/doi.org\/10.1371\/journal.ppat.1006523","journal-title":"PLoS Pathog"},{"key":"1111_CR21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.4049\/jimmunol.167.2.902","volume":"167","author":"LC Gavrilescu","year":"2001","unstructured":"Gavrilescu LC, Denkers EY (2001) IFN-\u03b3 overproduction and high level apoptosis are associated with high but not low virulence Toxoplasma gondii. Infect J Immunol 167:902\u2013909","journal-title":"Infect J Immunol"},{"key":"1111_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-1-4020-7846-0_5","volume-title":"opportunistic infections: Toxoplasma, Sarcocystis, and Microsporidia","author":"S Halonen","year":"2004","unstructured":"Halonen S (2004) Immune responses to Toxoplasma gondii in the central nervous system. In: Lindsay DS, Weiss LM (eds) opportunistic infections: Toxoplasma, Sarcocystis, and Microsporidia. Kluwer, Boston, pp 67\u201388. https:\/\/doi.org\/10.1007\/978-1-4020-7846-0_5"},{"key":"1111_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/JPR.1000130","volume":"2","author":"MA Hassanain","year":"2018","unstructured":"Hassanain MA, Elfadaly HA, Abd El Wahab WM, Abo El-Maaty AM (2018) Comparative hormonal and immunoglobulin profiles of aborted women with or without toxoplasmosis. J Pregnancy Reprod 2:1\u20134. https:\/\/doi.org\/10.15761\/JPR.1000130","journal-title":"J Pregnancy Reprod"},{"key":"1111_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/infdis\/124.6.587","volume":"124","author":"JB Hibbs","year":"1971","unstructured":"Hibbs JB, Lambert LH, Remington JS (1971) Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis 124:587\u2013592","journal-title":"J Infect Dis"},{"key":"1111_CR26","first-page":"165","volume":"18","author":"H Huang","year":"2000","unstructured":"Huang H, Yan F, Li C, Zhao MY, Tang JW, Li XR (2000) Detection of Toxoplasma infection in women with gynaecologic neoplasms using ELISA. Chin J Parasitol Parasit Dis 18:165\u2013166","journal-title":"Chin J Parasitol Parasit Dis"},{"key":"1111_CR27","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.4049\/jimmunol.166.10.5878","volume":"166","author":"CA Hunter","year":"2001","unstructured":"Hunter CA, Yu D, Gee M, Ngo CV, Sevignani C, Goldschmidt M, Golovkina TV, Evans S, Lee WF, Thomas-Tikhonenko A (2001) Cutting edge: systemic inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosis. J Immunol 166:5878\u20135881. https:\/\/doi.org\/10.4049\/jimmunol.166.10.5878","journal-title":"J Immunol"},{"key":"1111_CR28","doi-asserted-by":"publisher","first-page":"e2274","DOI":"10.1097\/MD.0000000000002274","volume":"94","author":"C Jiang","year":"2015","unstructured":"Jiang C, Li Z, Chen P, Chen L (2015) The seroprevalence of Toxoplasma gondii in Chinese population with cancer: a systematic review and meta-analysis. Medicine (Baltimore) 94:e2274. https:\/\/doi.org\/10.1097\/MD.0000000000002274","journal-title":"Medicine (Baltimore)"},{"key":"1111_CR29","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.4269\/ajtmh.14-0013","volume":"90","author":"JL Jones","year":"2014","unstructured":"Jones JL, Kruszon-Moran D, Rivera HN, Price C, Wilkins PP (2014) Toxoplasma gondii seroprevalence in the United States 2009\u20132010 and comparison with the past two decades. Am J Trop Med Hyg 90:1135\u20131139. https:\/\/doi.org\/10.4269\/ajtmh.14-0013","journal-title":"Am J Trop Med Hyg"},{"key":"1111_CR30","first-page":"45","volume":"11","author":"NF Jumaian","year":"2005","unstructured":"Jumaian NF (2005) Seroprevalence and risk factors for Toxoplasma infection in pregnant women in Jordan. East Mediterr Health J 11:45\u201351","journal-title":"East Mediterr Health J"},{"key":"1111_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.22088\/acadpub.BUMS.6.3.190","volume":"6","author":"N Kalantari","year":"2017","unstructured":"Kalantari N, Darabi ZA, Siadati S, Nikbakhsh N, Ghasemi M, Ghaffari T, Ghaffari S, Bayani M (2017) Detection of Toxoplasma gondii DNA in malignant breast tissues in breast cancer patients. Int J Mol Cell Med 6:190\u2013196. https:\/\/doi.org\/10.22088\/acadpub.BUMS.6.3.190","journal-title":"Int J Mol Cell Med"},{"key":"1111_CR32","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","volume":"95","author":"DH Kaplan","year":"1998","unstructured":"Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD (1998) Demonstration of an interferon gamma dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 95:7556\u20137561. https:\/\/doi.org\/10.1073\/pnas.95.13.7556","journal-title":"Proc Natl Acad Sci USA"},{"key":"1111_CR33","first-page":"657","volume":"21","author":"HM Khalil","year":"1991","unstructured":"Khalil HM, Makled MK, Azab ME, Abdalla HM, el Sherif EA, Nassef NS (1991) Opportunistic parasitic infections in immunocompromised hosts. J Egypt Soc Parasitol 21:657\u2013658","journal-title":"J Egypt Soc Parasitol"},{"key":"1111_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/0255-0857.16044","volume":"23","author":"S Khurana","year":"2005","unstructured":"Khurana S, Dubey ML, Malla N (2005) Association of parasitic infections and cancers. Indian J Med Microbiol 23:74\u201379","journal-title":"Indian J Med Microbiol"},{"key":"1111_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/030089161009600123","volume":"96","author":"M Kojima","year":"2010","unstructured":"Kojima M, Nakamura N, Murayama K, Igarashi T, Matsumoto M, Matsuda H et al (2010) Reactive lymphoid hyperplasia with giant follicles associated with a post therapeutic state of hematological malignancies. A report of eight cases. Tumori J 96:143\u2013148","journal-title":"Tumori J"},{"key":"1111_CR36","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1590\/S0004-282X2000000600019","volume":"58","author":"E Maciel","year":"2000","unstructured":"Maciel E, Siqueira I, Queiroz AC, Melo A (2000) Toxoplasma gondii myelitis in a patient with adult T-cell leukemia-lymphoma. Arq Neuropsiquiatr 58:1107\u20131109","journal-title":"Arq Neuropsiquiatr"},{"issue":"7378","key":"1111_CR37","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature10673","volume":"480","author":"I Mellman","year":"2011","unstructured":"Mellman I, Coukos G, Dranoff G (2011) Cancer immunotherapy comes of age. Nature 480(7378):480\u2013489. https:\/\/doi.org\/10.1038\/nature10673","journal-title":"Nature"},{"key":"1111_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.12861\/jrip.2014.25","volume":"3","author":"R Mohammadi Manesh","year":"2014","unstructured":"Mohammadi Manesh R, Hosseini Safa A, Sharafi SM, Jafari R, Bahadoran M, Yousefi M, Hamid Nasri H, Darani HY (2014) Parasites and chronic renal failure. J Renal Inj Prev 3:87\u201390. https:\/\/doi.org\/10.12861\/jrip.2014.25","journal-title":"J Renal Inj Prev"},{"key":"1111_CR39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3855\/jidc.9672","volume":"12","author":"NE Mostafa","year":"2018","unstructured":"Mostafa NE, Abdel Hamed EF, Rahed HE, Mohamed SY, Abdelgawad M, Elasbali AM (2018) The relationship between toxoplasmosis and different types of human tumors. J Infect Dev Ctries 12:137\u2013141. https:\/\/doi.org\/10.3855\/jidc.9672","journal-title":"J Infect Dev Ctries"},{"key":"1111_CR40","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","volume":"39","author":"G Pappas","year":"2009","unstructured":"Pappas G, Roussos N, Falagas ME (2009) Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 39:1385\u20131394. https:\/\/doi.org\/10.1016\/j.ijpara.2009.04.003","journal-title":"Int J Parasitol"},{"key":"1111_CR41","first-page":"487","volume":"8","author":"W Phuangphet","year":"2008","unstructured":"Phuangphet W (2008) Toxoplasmosis: pathogenesis and immune response. Thammasat Med J 8:487","journal-title":"Thammasat Med J"},{"key":"1111_CR42","first-page":"200","volume":"21","author":"M Polat","year":"2012","unstructured":"Polat M, Kilic E, Yazar S (2012) Assessment of advanced positive oxidation product levels in Toxoplasma gondii positive individuals. J Health Sci 21:200\u2013204","journal-title":"J Health Sci"},{"key":"1111_CR43","first-page":"89","volume":"5","author":"SK Rai","year":"2003","unstructured":"Rai SK, Upadhyay MP, Shrestha HG (2003) Toxoplasma infection in selected patients in Kathmandu, Nepal. Nepal Med Coll J 5:89\u201391","journal-title":"Nepal Med Coll J"},{"key":"1111_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3923\/jp.2014.55.63","volume":"9","author":"MM Sanad","year":"2014","unstructured":"Sanad MM, Thagfan FA, Al Olayan EM, Almogren A, Al Hammaad A, Al-Mawash A et al (2014) Opportunistic coccidian parasites among Saudi cancer patients presenting with diarrhea: prevalence and immune status. Res J Parasitol 9:55\u201363. https:\/\/doi.org\/10.3923\/jp.2014.55.63","journal-title":"Res J Parasitol"},{"key":"1111_CR45","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/2326-6066.CIR-14-0235","volume":"3","author":"KL Sanders","year":"2015","unstructured":"Sanders KL, Fox BA, Bzik DJ (2015) Attenuated Toxoplasma gondii stimulates immunity to pancreatic cancer by manipulation of myeloid cell populations. Cancer Immunol Res 3:891\u2013901. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0235","journal-title":"Cancer Immunol Res"},{"key":"1111_CR46","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/35074122","volume":"410","author":"V Shankaran","year":"2001","unstructured":"Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ et al (2001) IFN gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410:1107\u20131111. https:\/\/doi.org\/10.1038\/35074122","journal-title":"Nature"},{"key":"1111_CR47","first-page":"2031","volume":"42","author":"DF Shen","year":"2001","unstructured":"Shen DF, Matteson DM, Tuaillon N, Suedekum BK, Buggage RR, Chan CC (2001) Involvement of apoptosis and interferon-g in murine toxoplasmosis. IOVS 42:2031\u20132036","journal-title":"IOVS"},{"key":"1111_CR48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1756-0500-2-213","volume":"2","author":"T Shimelis","year":"2009","unstructured":"Shimelis T, Tebeje M, Tadesse E, Tegbaru B, Terefe A (2009) Sero-prevalence of latent Toxoplasma gondii infection among HIV-infected and HIV-uninfected people in Addis Ababa Ethiopia: a comparative cross-sectional study. BMC Res Notes 2:213. https:\/\/doi.org\/10.1186\/1756-0500-2-213","journal-title":"BMC Res Notes"},{"key":"1111_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3347\/kjp.2009.47.2.125","volume":"47","author":"DW Shin","year":"2009","unstructured":"Shin DW, Cha DY, Hua QJ, Cha G, Lee Y (2009) Seroprevalence of Toxoplasma gondii infection and characteristics of seropositive patients in general hospitals in Daejeon, Korea. Korean J Parasitol 47:125\u2013130. https:\/\/doi.org\/10.3347\/kjp.2009.47.2.125","journal-title":"Korean J Parasitol"},{"key":"1111_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1084\/jem.20020063","volume":"196","author":"SE Street","year":"2002","unstructured":"Street SE, Trapani JA, MacGregor D, Smyth MJ (2002) Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med 196:129\u2013134","journal-title":"J Exp Med"},{"key":"1111_CR51","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1017\/S1462399411002018","volume":"13","author":"Y Suzuki","year":"2012","unstructured":"Suzuki Y, Sa Q, Gehman M, Ochiai E (2012) Interferon-gamma- and perforin-mediated immune responses for resistance in the brain against Toxoplasma gondii. Expert Rev Mol Med 13:e31. https:\/\/doi.org\/10.1017\/S1462399411002018","journal-title":"Expert Rev Mol Med"},{"key":"1111_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1756-3305-6-15","volume":"6","author":"F Walle","year":"2013","unstructured":"Walle F, Kebede N, Tsegaye A, Kassa T (2013) Seroprevalence and risk factors for toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia. Parasit Vectors 6:15. https:\/\/doi.org\/10.1186\/1756-3305-6-15","journal-title":"Parasit Vectors"},{"key":"1111_CR53","first-page":"224","volume":"18","author":"B Wang","year":"2000","unstructured":"Wang B, Pan X, Yin Y, Weng XH (2000) Investigation of anti-Toxoplasma gondii antibodies in immunodeficient patients. Chin J Parasitol Parasit Dis 18:224\u2013226","journal-title":"Chin J Parasitol Parasit Dis"},{"key":"1111_CR54","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13071-015-0778-5","volume":"15","author":"L Wang","year":"2015","unstructured":"Wang L, He LY, Meng DD, Chen ZW, Wen H, Fang GS (2015) Seroprevalence and genetic characterization of Toxoplasma gondii in cancer patients in Anhui Province, Eastern China. Parasit Vectors 15:162. https:\/\/doi.org\/10.1186\/s13071-015-0778-5","journal-title":"Parasit Vectors"},{"key":"1111_CR55","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fmicb.2017.00389","volume":"8","author":"ZD Wang","year":"2017","unstructured":"Wang ZD, Liu HH, Ma ZX, Ma HY, Li ZY, Yang ZB et al (2017) Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis. Front Microbiol 8:389. https:\/\/doi.org\/10.3389\/fmicb.2017.00389","journal-title":"Front Microbiol"},{"key":"1111_CR56","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1099\/jmm.0.45587-0","volume":"53","author":"S Yazar","year":"2004","unstructured":"Yazar S, Yaman O, Eser B, Altuntas F, Kurnaz F, Sahin I (2004) Investigation of anti- toxoplasma gondii antibodies in patients with neoplasia. J Med Microbiol 53:1183\u20131186. https:\/\/doi.org\/10.1099\/jmm.0.45587-0","journal-title":"J Med Microbiol"},{"key":"1111_CR57","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1056\/NEJMc051556","volume":"353","author":"JD Young","year":"2005","unstructured":"Young JD, McGwire BS (2005) Infliximab and reactivation of cerebral toxoplasmosis. N Engl J Med 353:1530\u20131531. https:\/\/doi.org\/10.1056\/NEJMc051556","journal-title":"N Engl J Med"}],"container-title":["Journal of Parasitic Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12639-019-01111-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12639-019-01111-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12639-019-01111-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:43:30Z","timestamp":1721130210000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12639-019-01111-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1111"],"URL":"https:\/\/doi.org\/10.1007\/s12639-019-01111-9","relation":{},"ISSN":["0971-7196","0975-0703"],"issn-type":[{"value":"0971-7196","type":"print"},{"value":"0975-0703","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,30]]},"assertion":[{"value":"2 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}